Skip to main content

Table 3 Comparison of each test index between gastric cancer population and healthy population

From: Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer

Groups

Control Group

GC Group

Z Value

P Value

N

80

293

t-PAIC (ng/mL)

4.43 (2.96,6.60)

4.49 (3.00,6.89)

-0.288

0.773

TM (TU/mL)

6.75 (5.21,8.44)

7.84 (5.73,11.61)

-3.564

<0.001

TAT (ng/mL)

2.60 (2.13,3.71)

8.91 (5.75,12.89)

-12.171

<0.001

PIC (μg/mL)

0.32 (0.20,0.50)

0.68 (0.47,0.94)

-9.188

<0.001

D-D (mg/L)

0.36 (0.25,0.46)

0.85 (0.40,2.26)

-7.952

<0.001

FDP (mg/L)

3.35 (2.35,4.30)

3.40 (2.10,7.20)

-2.017

0.044

  1. Abbreviation: GC Gastric cancer, t-PAIC Tissue plasminogen activator inhibitor complex, TAT Thrombin-antithrombin complex, TM Thrombomodulin, PIC Plasmin-α2-plamininhibitor complex, D-D D-Dimer, FDP Fibrinogen degradation product
  2. * P < 0.05 considered statistically significant